As of 2026-04-01, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (2.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.56 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -267.2%.
The range of the Relative Valuation is (2.47) - (2.63) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.3x - 24.6x | 22.5x |
| Forward P/E multiples | 20.8x - 22.1x | 21.5x |
| Fair Price | (2.47) - (2.63) | (2.61) |
| Upside | -258.4% - -268.3% | -267.2% |
| Date | P/E |
| 2026-03-24 | -14.48 |
| 2026-03-23 | -13.80 |
| 2026-03-20 | -13.13 |
| 2026-03-19 | -13.63 |
| 2026-03-18 | -13.13 |
| 2026-03-17 | -13.63 |
| 2026-03-16 | -13.55 |
| 2026-03-13 | -14.22 |
| 2026-03-12 | -14.48 |
| 2026-03-11 | -14.48 |
| 2026-03-10 | -13.97 |
| 2026-03-09 | -14.14 |
| 2026-03-06 | -14.39 |
| 2026-03-05 | -13.80 |
| 2026-03-04 | -13.72 |
| 2026-03-03 | -13.55 |
| 2026-03-02 | -13.13 |
| 2026-02-27 | -12.37 |
| 2026-02-26 | -12.62 |
| 2026-02-25 | -12.62 |
| 2026-02-24 | -12.46 |
| 2026-02-23 | -12.71 |
| 2026-02-20 | -12.37 |
| 2026-02-19 | -12.79 |
| 2026-02-18 | -11.11 |
| 2026-02-17 | -11.11 |
| 2026-02-13 | -11.03 |
| 2026-02-12 | -11.03 |
| 2026-02-11 | -11.53 |
| 2026-02-10 | -11.03 |
| 2026-02-09 | -10.10 |
| 2026-02-06 | -10.35 |
| 2026-02-05 | -9.93 |
| 2026-02-04 | -10.69 |
| 2026-02-03 | -10.77 |
| 2026-02-02 | -10.52 |
| 2026-01-30 | -9.76 |
| 2026-01-29 | -12.12 |
| 2026-01-28 | -12.62 |
| 2026-01-27 | -14.39 |
| 2026-01-26 | -13.21 |
| 2026-01-23 | -14.31 |
| 2026-01-22 | -14.81 |
| 2026-01-21 | -13.13 |
| 2026-01-20 | -11.03 |
| 2026-01-16 | -11.53 |
| 2026-01-15 | -10.77 |
| 2026-01-14 | -10.44 |
| 2026-01-13 | -10.10 |
| 2026-01-12 | -9.93 |